This monthly feature focuses on various tranches and rounds of funding for healthcare ventures, startups and funds. Links indicate target companies and lead investors.
Target | Investors | Amount | Date |
---|---|---|---|
Theranics Bio-Electronics | Lightspeed Venture Partners, LionBird and Corundum Open Innovation | $6 million, Series A | July 3, 2017 |
Diasome Pharmaceuticals, Inc. | Medicxi Ventures, JDRF T1D Fund, Black Beret Life Sciences, LLC and McDonald Partners, LLC | $30 million | July 5, 2017 |
Omni Eye Services | New MainStream Capital | Undisclosed | July 6, 2017 |
Genoox | Inimiti Capital Partners and Glilot Capital | $6 million | July 11, 2017 |
Allurion Technologies | Romulus Capital, with Cogepa Investments and IDO Investments | $27 million, Series C | July 11, 2017 |
Evelo Biosciences | Flagship Pioneering, Google Ventures, Celgene, Mayo Clinic and Alexandria Venture Investments | $50 million, Series B | July 11, 2017 |
Machtfit | Seventure Partners | $2.6 million, Series A | July 11, 2017 |
Push Doctor | Seventure Partners | $27.1 million, Series B | July 11, 2017 |
Actinobac Biomed | Kairos Ventures | $4.4 million | July 12, 2017 |
BloomAPI | Y Combinator, Slow Ventures, Founders' Co-Op, Section 32, Liquid 2 Ventures and Parker Conrad | $2.4 million | July 14, 2017 |
Bright.md | B Capital Group and Seven Peaks Ventures | $8 million, Series B | July 17, 2017 |
Silk Road Medical | Northwest Venture Partners, with Janus Capital Management, Warburg Pincus, the Vertical Group and CRG | $47 million | July 18, 2017 |
Trevi Therapeutics | New Enterprise Associates, with TPG Biotech, Lundebeckfonden Ventures, Omega Funds and Aperture Venture Partners | $50.5 million, Series C | July 20, 2017 |
Allegro Ophthalmics | Not disclosed | $10.7 million | July 24, 2017 |
Sebacia, Inc. | Versant Ventures, Domain Associates, Accuitive Medical Ventures and Partners Healthcare Innovation Fund | $20 million, Series D | July 25, 2017 |
Okami Medical | Inceptus Medical, LLC | $4.5 million, Series B | July 25, 2017 |
VenatoRx Pharmaceuticals, Inc. | Versant Ventures, with Abingworth and Foresite Capital | $42 million, Series C | July 25, 2017 |
PreciThera | Sanderling Ventures, Arix Bioscience, Fons de solidarite FTQ, CTI Life Scienes and Emerillon Capital | $29 million, Series A | July 27, 2017 |